The neurologic significance of celiac disease biomarkers

Neurology

Volumn 83, Issue 20, 2014, Pages 1789-1796

  McKeon, Andrew ^a   Lennon, Vanda A ^a,b   Pittock, Sean J ^a   Kryzer, Thomas J ^a   Murray, Joseph ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLIADIN ANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LA ANTIBODY; NEUROLEPTIC AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; RABEPRAZOLE; RHEUMATOID FACTOR; RO ANTIBODY; VOLTAGE GATED POTASSIUM CHANNEL; ANTIBODY; CALCIUM CHANNEL; CHOLINERGIC RECEPTOR; GLIADIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HLA DQ ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; AKATHISIA; ALPHA TOCOPHEROL DEFICIENCY; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CEREBELLAR ATAXIA; CHILD; CONTROLLED STUDY; COPPER DEFICIENCY; DEAMINATION; DEMENTIA; DIETARY COMPLIANCE; DRUG WITHDRAWAL; FEMALE; FOLIC ACID DEFICIENCY; GLUTEN FREE DIET; HAPLOTYPE; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALABSORPTION; MALE; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; NEUROPATHY; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SPINAL CORD DISEASE; ANIMAL; BLOOD; CEREBROSPINAL FLUID; COMPLICATION; HAPLORHINI; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOUSE; PERIPHERAL NEUROPATHY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; CALCIUM CHANNELS; CELIAC DISEASE; CEREBELLAR ATAXIA; CHILD; FEMALE; GLIADIN; GTP-BINDING PROTEINS; HAPLORHINI; HLA-DQ ANTIGENS; HUMANS; MALE; MICE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, CHOLINERGIC; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84925283670     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000970     Document Type: Article

References (39)

1. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62: 43-52.
2. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-350.
3. Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 1992;40:90-97.
4. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297-303.
5. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain 1966;89:683-722.
6. Halfdanarson TR, Kumar N, Hogan WJ, Murray JA. Copper deficiency in celiac disease. J Clin Gastroenterol 2009;43:162-164.
7. Harding AE, Muller DP, Thomas PK, Willison HJ. Spinocerebellar degeneration secondary to chronic intestinal malabsorption: A vitamin E deficiency syndrome. Ann Neurol 1982;12:419-424.
8. Mauro A, Orsi L, Mortara P, Costa P, Schiffer D. Cerebellar syndrome in adult celiac disease with vitamin E deficiency. Acta Neurol Scand 1991;84:167-170.
9. Dimberg EL, Crowe SE, Trugman JM, et al. Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm. Mov Disord 2007; 22:407-411.
10. Lock RJ, Pengiran Tengah DS, Unsworth DJ, Ward JJ, Wills AJ. Ataxia, peripheral neuropathy, and anti-gliadin antibody: guilt by association? J Neurol Neurosurg Psychiatry 2005;76:1601-1603.
11. Signer E, Burgin-Wolff A, Berger R, Birbaumer A, Just M. Antibodies to gliadin as a screening test for coeliac disease: A prospective study. Helv Paediatr Acta 1979;34:41-52.
12. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131:1981-2002.
13. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996; 347:369-371.
14. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352:1582-1585.
15. Hadjivassiliou M, Grunewald RA, Lawden M, Davies- Jones GA, Powell T, Smith CM. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 2001;56:385-388.
16. Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grunewald RA, Davies-Jones AG. Sensory ganglionopathy due to gluten sensitivity. Neurology 2010;75:1003-1008.
17. Hadjivassiliou M, Sanders DS, Grunewald RA. Multiple sclerosis and occult gluten sensitivity. Neurology 2005;64: 933-934.
18. Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: From gut to brain. Lancet Neurol 2010;9:318-330.
19. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008;64:332-343.
20. Thomas H, Beck K, Adamczyk M, et al. Transglutaminase 6: A protein associated with central nervous system development and motor function. Amino Acids 2013;44:161-177.
21. Hadjivassiliou M, Aeschlimann P, Sanders DS, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology 2013;80:1740-1745.
22. O'Toole O, Lennon VA, Ahlskog JE, et al. Autoimmune chorea in adults. Neurology 2013;80:1133-1144.
23. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: Oncological, neurological, and serological accompaniments. Arch Neurol 2009;66:735-741.
24. Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001;49:540-543.
25. Lindfors K, Koskinen O, Laurila K, et al. IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency. Clin Chim Acta 2011;412:1187-1190.
26. Fukui M, Kuramoto K, Yamasaki R, et al. Identification of a highly reactive substrate peptide for transglutaminase 6 and its use in detecting transglutaminase activity in the skin epidermis. FEBS J 2013;280:1420-1429.
27. Klein C, Lennon VA, Aston PA, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 2013;70:229-234.
28. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322:1555-1560.
29. Pittock SJ, Yoshikawa H, Ahlskog JE, et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 2006; 81:1207-1214.
30. Briani C, Doria A, Ruggero S, et al. Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. Autoimmunity 2008;41:100-104.
31. Hadjivassiliou M, Aeschlimann D, Grunewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibodyassociated neurological illness and its relationship to gluten sensitivity. Acta Neurol Scand 2011;123:175-180.
32. Stordal K, Bakken IJ, Suren P, Stene LC. Epidemiology of coeliac disease and comorbidity in Norwegian children. J Pediatr Gastroenterol Nutr 2013;57:467-471.
33. Wierdsma NJ, va nBokhorst-de van der Schueren MA, Berkenpas M, Mulder CJ, van Bodegraven AA. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients 2013;5:3975- 3992.
34. Terril-Robb LA, Clemons DJ, Besch-Williford C, O'Brien DP, O'Dell BL. Morphophysiologic characterization of peripheral neuropathy in zinc-deficient guinea pigs. Proc Soc Exp Biol Med 1996;213:50-58.
35. O'Dell BL, Conley-Harrison J, Browning JD, Besch- Williford C, Hempe JM, Savage JE. Zinc deficiency and peripheral neuropathy in chicks. Proc Soc Exp Biol Med 1990;194:1-4.
36. Boscolo S, Lorenzon A, Sblattero D, et al. Anti transglutaminase antibodies cause ataxia in mice. PLoS One 2010; 5:e9698.
37. Hadjivassiliou M, Maki M, Sanders DS, et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006;66:373-377.
38. Solimena M, Folli F, Denis-Donini S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiffman syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-1020.
39. Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc 1998;73:1161-1166.